Download DNB 2016 Dec GASTROENTEROLOGY PAPER 3 Question Paper

Download Diplomate of National Board (DNB) 2016 Dec GASTROENTEROLOGY PAPER 3 Previous Question Paper

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
GASTROENTEROLOGY

PAPER ? III
GASTRO/D/16/10/III
Time : 3 hours
Max. Marks : 100

Important instructions:

? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. Surveillance of patients with inflammatory bowel disease:
a) High risk groups ? screening and surveillance timing.
b) SCENIC consensus guidelines.
c) Methods of surveillance.

2+5+3
2. a) Changing epidemiology of Asian digestive cancers.
b) Screening of gastric cancer in Asia.
c) Targeted screening for colorectal cancer in high risk
individuals.

3+3+4
3. a) Image enhanced endoscopy: Technique
b) Advanced endoscopic imaging for early gastric cancer.

5+5
4. a) Non-celiac wheat sensitivity: differential diagnosis, triggers and
implications.
b) Complications of celiac disease.
c) Therapeutic approaches for celiac disease.

4+3+3
5. a) Risk assessment tools in prognostication of patients with non
variceal upper GI bleed.
b) Management of steroid dependent ulcerative colitis.

5+5
6. Epidemiology, risk factors, patterns of presentation, diagnosis and
management of colon ischaemia.

2+2+2+2+2
7. Enumerate newer therapeutic strategies for the following
diseases:
a) Primary sclerosing cholangitis.
b) Primary biliary cirrhosis beyond ursodeoxycholic acid.
c) Targeting dysbiosis for liver diseases.
d) Alcoholic hepatitis.
e) Nuclear receptor modulation for non-alcoholic fatty liver
disease.


2+2+2+2+2






P.T.O.

FirstRanker.com - FirstRanker's Choice
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
GASTROENTEROLOGY

PAPER ? III
GASTRO/D/16/10/III
Time : 3 hours
Max. Marks : 100

Important instructions:

? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. Surveillance of patients with inflammatory bowel disease:
a) High risk groups ? screening and surveillance timing.
b) SCENIC consensus guidelines.
c) Methods of surveillance.

2+5+3
2. a) Changing epidemiology of Asian digestive cancers.
b) Screening of gastric cancer in Asia.
c) Targeted screening for colorectal cancer in high risk
individuals.

3+3+4
3. a) Image enhanced endoscopy: Technique
b) Advanced endoscopic imaging for early gastric cancer.

5+5
4. a) Non-celiac wheat sensitivity: differential diagnosis, triggers and
implications.
b) Complications of celiac disease.
c) Therapeutic approaches for celiac disease.

4+3+3
5. a) Risk assessment tools in prognostication of patients with non
variceal upper GI bleed.
b) Management of steroid dependent ulcerative colitis.

5+5
6. Epidemiology, risk factors, patterns of presentation, diagnosis and
management of colon ischaemia.

2+2+2+2+2
7. Enumerate newer therapeutic strategies for the following
diseases:
a) Primary sclerosing cholangitis.
b) Primary biliary cirrhosis beyond ursodeoxycholic acid.
c) Targeting dysbiosis for liver diseases.
d) Alcoholic hepatitis.
e) Nuclear receptor modulation for non-alcoholic fatty liver
disease.


2+2+2+2+2






P.T.O.

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-2-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
GASTROENTEROLOGY

PAPER ? III

8. In relation to functional gastrointestinal disorders (FGIDs):
a) Changes in Rome IV document compared to Rome III.
b) Multicultural aspects in FGIDs.
c) Centrally mediated disorders of gastrointestinal pain.

4+3+3
9. a) Endoscopic management approach to a patient with Type II
Forrest classification of bleeding peptic ulcer.
b) Management of a patient with diverticular bleed.

5+5
10. a) Principle and indications of magnetic resonance spectroscopy
in GI Practice.
b) Indications of Diffusion-weighted magnetic resonance imaging
in GI Practice.
c) Indications of SX-ELLA Stent Danis.

4+3+3
**********************
FirstRanker.com - FirstRanker's Choice